Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/25/2025

Tapering Off Venlafaxine 225 mg After Two Years of Use

Introduction to Tapering

  • For patients using venlafaxine for ≥1 year, reductions of 10% per month or slower are better tolerated than rapid reductions, according to the MMWR Recommendations and Reports 1
  • The reduction rate should be determined by the patient's tolerance to withdrawal symptoms, not by a rigid schedule, as suggested by Praxis Medical Insights: Practical Summaries of Clinical Guidelines 2
  • The American College of Cardiology is not mentioned, however, the Mayo Clinic Proceedings recommends a tapering schedule, for example, from 225 mg to 150 mg over 8 weeks, with reductions of 10% of the current dose every 2-4 weeks 3, 4
  • The Centers for Disease Control and Prevention, as reported in MMWR Recommendations and Reports, suggests that patients who have used venlafaxine for prolonged periods may need reductions over several months to years 1

Monitoring During Tapering

  • The patient should be monitored at least monthly during the entire tapering process, with more frequent contact during difficult phases, as recommended by Praxis Medical Insights: Practical Summaries of Clinical Guidelines 2
  • Monitoring should include signs of depression, anxiety, and possible relapse, according to MMWR Recommendations and Reports 1

Management of Withdrawal Symptoms

  • Clinically significant withdrawal symptoms signal the need to further reduce the tapering speed, as suggested by MMWR Recommendations and Reports 1
  • Pausing the taper and resuming at a slower rate may be necessary when withdrawal symptoms emerge, according to Praxis Medical Insights: Practical Summaries of Clinical Guidelines 2

Adjuvant Strategies to Increase Success

  • Cognitive-behavioral therapy (CBT) during tapering significantly increases success rates, as reported by Praxis Medical Insights: Practical Summaries of Clinical Guidelines 2
  • Patient education about the risks of venlafaxine and the benefits of discontinuation improves outcomes and engagement, according to Praxis Medical Insights: Practical Summaries of Clinical Guidelines 2

Special Considerations

  • The patient's agreement and interest in tapering is a key component of success, as suggested by Praxis Medical Insights: Practical Summaries of Clinical Guidelines 2
  • Realistic goals should be set, and the patient should be informed that the tapering process may take several months to years, according to MMWR Recommendations and Reports 1
  • The goal is durability of the taper, not speed, as reported by Praxis Medical Insights: Practical Summaries of Clinical Guidelines 5